BRPI0512948A - biomarcadores de mal de alzheimer - Google Patents

biomarcadores de mal de alzheimer

Info

Publication number
BRPI0512948A
BRPI0512948A BRPI0512948-6A BRPI0512948A BRPI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A
Authority
BR
Brazil
Prior art keywords
alzheimer
disease
biomarkers
test
diagnosing
Prior art date
Application number
BRPI0512948-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Simon Lovestone
Original Assignee
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King S College London filed Critical King S College London
Publication of BRPI0512948A publication Critical patent/BRPI0512948A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0512948-6A 2004-07-02 2005-07-01 biomarcadores de mal de alzheimer BRPI0512948A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0414894.6A GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease
PCT/GB2005/002592 WO2006003414A2 (fr) 2004-07-02 2005-07-01 Biomarqueurs de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
BRPI0512948A true BRPI0512948A (pt) 2008-04-15

Family

ID=32843494

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512948-6A BRPI0512948A (pt) 2004-07-02 2005-07-01 biomarcadores de mal de alzheimer

Country Status (9)

Country Link
US (1) US20080076140A1 (fr)
EP (1) EP1763674A2 (fr)
JP (1) JP2008504551A (fr)
CN (1) CN101010589A (fr)
AU (1) AU2005258926A1 (fr)
BR (1) BRPI0512948A (fr)
CA (1) CA2571692A1 (fr)
GB (1) GB0414894D0 (fr)
WO (1) WO2006003414A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138408A1 (fr) 2006-05-25 2007-12-06 Ge Healthcare Limited Inhibiteurs marqués 11c/18 f de la glycogène synthase kinase-3
WO2009074331A2 (fr) * 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Test diagnostique precoce et differentiel de la maladies d'alzheimer
CA2718955C (fr) 2008-03-21 2015-10-13 Manuela G. Neuman Procedes et necessaires pour le diagnostic differentiel de la maladie d'alzheimer comparee a la demence frontotemporale et pour le diagnostic de la demence frontotemporale, ces procedes et necessaires comprenant fas-l et ckl 18 en tant que biomarqueurs
US20100151457A1 (en) * 2008-12-17 2010-06-17 National Tsing Hua University Detection of Unhealthy Cell and Uses Thereof
US20120040361A1 (en) * 2010-07-22 2012-02-16 National Tsing Hua University Methods and compositions for detection of lethal system and uses thereof
CN104237526B (zh) * 2013-06-18 2016-08-17 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
WO2015134726A1 (fr) * 2014-03-05 2015-09-11 Humanetics Corporation Prévision et réduction du déclin cognitif basés sur les niveaux de gsk -3
CN104698188A (zh) * 2015-03-04 2015-06-10 华中科技大学 检测人血小板GSK-3β蛋白活性的斑点印迹方法
CN111323597A (zh) * 2018-12-14 2020-06-23 陈志成 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041862A1 (en) * 2004-05-07 2009-02-12 Peter Robert Schofield Detecting disease association with aberrant glycogen synthase kinase 3beta expression

Also Published As

Publication number Publication date
CN101010589A (zh) 2007-08-01
WO2006003414A3 (fr) 2006-03-16
JP2008504551A (ja) 2008-02-14
CA2571692A1 (fr) 2006-01-12
EP1763674A2 (fr) 2007-03-21
US20080076140A1 (en) 2008-03-27
WO2006003414A2 (fr) 2006-01-12
AU2005258926A1 (en) 2006-01-12
GB0414894D0 (en) 2004-08-04

Similar Documents

Publication Publication Date Title
BRPI0512948A (pt) biomarcadores de mal de alzheimer
Kocur et al. Relationship between age, BMI, head posture and superficial neck muscle stiffness and elasticity in adult women
EP2287617A3 (fr) Procédé pour la diagnostic de maladies neuro-dégénératives
BR0206604A (pt) Dispositivo de lanceta que tem ação capilar
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
WO2006073682A3 (fr) Test diagnostique
EP2386860A3 (fr) Prédiction de la mortalité et détection de maladies graves
WO2005034008A3 (fr) Procede d'essai anonyme et fourniture de resultats d'essai a un patient
EP1745739A3 (fr) Imagerie optique de la polyarthrite rhumatoïde
BRPI0720035A2 (pt) métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit
EP2634574A3 (fr) Dispositif de cartouche pour système de mesure pour la mesure de propriétés visco-élastiques dýun échantillon liquide, système de mesure correspondant et procédé correspondant
DE60228557D1 (de) Candida-nachweis
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
WO2008132464A3 (fr) Procédés
WO2007015113A3 (fr) Nouveaux isoformes de proteines et leurs utilisations
ATE415632T1 (de) Verfahren zur diagnose und behandlung von morbus crohn
WO2008080030A3 (fr) Panel de maladies auto-immunes cardiovasculaires et méthodes d'utilisation correspondantes
NZ599054A (en) Diagnosis of collagen IX destruction
WO2006113880A3 (fr) Proteine igfbp-3 utilisee comme facteur indicateur de risque de cancer du colon chez des patients atteints de maladie intestinale inflammatoire
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
WO2003088811A3 (fr) Gelsoline utilisee en tant que marqueur pronostique de maladies atherosclereuses
BR0317404A (pt) Variantes do fator xiia
WO2006032021A3 (fr) Identification de gene associe a deficience de lecture et ses utilisation
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired